WHO recommends 2 new treatments
In the medical journal The BMJ, the World Health Organization advocated the arrival of two new treatments: baricitinib and sotrovimab. Intended for specific patients, the WHO has validated the sotrovimab, treatment with synthetic antibodies and the baricitinib, usually used against rheumatoid arthritis. Mild Covid and or severe or critical Covid Regarding sotrovimab, it is recommended … Read more